Pharmaceutical manufacturers of Metoclopramide

At BASF, we create chemistry – and have been doing so for 150 years. Our portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. As the world’s leading chemical company, we combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. Every day, our team members work on developing innovative solutions for customers around the world. Our employees’ passion, imagination, and determination are crucial to our success as a market leader. Whether you are a recent university graduate or an experienced professional, you have great ideas and skills, and BASF is the place to make your mark!

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 Biologics in the Domestic Market & RoW markets & they are the domestic leader in three biologics. With 350+ brands, five R&D centers and 13 manufacturing facilities established across the country, we have ensured a strong presence not just in India but also outside India with a wide network across 70+ countries. Our API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

COSMA S. P. A. (established in 1977) and AMSA S. P. A. (established in 1953) are a pair of chemical facilities widely recognized globally and particularly valued in the occidental world and in the nations that adhere to the Pharmaceutical Inspection Convention (PIC). They are part of the CFM Group, a privately-owned company engaged in the fields of chemistry and pharmaceuticals since 1949

Leading Italian expert in personalized development and contract manufacturing of Active Pharmaceutical Ingredients, ICROM is the exclusive firm for APIs. Utilizing advanced expertise, ICROM constructs high-tech solutions for synthesizing intricate molecules and creating adaptable, expandable, and economical processes tailored to clients’ requirements. With varying production capacities in 4 cutting-edge manufacturing facilities sanctioned by AIFA, USFDA, PMDA, KFDA, ICROM is the preferred partner for CDMO of NCEs, advanced generics, and your drive for innovation.

Shandong Chenghui Pharmaceutical Group Co., Ltd. was founded in June 2002 and is a full-scale pharmaceutical company that integrates research and development, manufacturing, and sales of pharmaceutical APIs, intermediates, CDMO, and MAH products. With robust research and innovation capabilities and a comprehensive quality management system, the company can meet the GMP standards of FDA, EU, China, Korea, Japan, and more.. Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. was established in 2014 and is situated in the economic development zone of Pingyuan County, Dezhou City, China. It specializes in producing local anesthesia drugs, cardiovascular drugs, nutritional drugs, hormone drugs, and food additives. The company operates a cutting-edge production line and adheres to GMP, FDA, and other certification requirements. It boasts eight production lines and is equipped with R&D and quality analysis control centers. The company carries out projects in accordance with GMP drug production standards as well as environmental, safety, and health regulations, from planning and design to production.

Established in 1977 and initially reviewed by the FDA in 1984, COSMA SpA stands as the primary facility within the group, specializing in high-volume APIs with a reaction volume surpassing 130 m3. A modern, cutting-edge expansion of production capabilities was completed in 2011 and 2012.

Benzo Chem Industries Pvt. Limited and Gitanjali Chemicals Pvt. Limited are wholly owned companies of Mohatta Group. It all began three decades ago in 1982; Gitanjali Chemicals Pvt. Limited was first incepted with the production of phthalate plasticizers. Soon, the company has developed substantial competencies in the areas of biocides, pharmaceuticals and performance chemicals. Today, the company’s range of products includes Chlorophenol derivatives, Diclofenac Sodium & Miconazole Nitrate & their intermediates.

China Resources Double-Crane Pharmaceutical Co Ltd engages in the development, production, and promotion of various healthcare goods. The corporation's range encompasses medications for combating influenza, controlling high blood pressure, and treating bacterial infections.

Heumann Pharma is a large, established pharmaceutical company with a lengthy history and a broad range of prescribed and non-prescribed medications. Established in 1913 by pastor Ludwig Heumann, Heumann Pharma is a pharmaceutical firm with a rich heritage and extensive expertise in manufacturing medications. When pastor Ludwig Heumann founded the company, his aim was to provide affordable medications and treatments to all. Even today, over a century later, we at Heumann Pharma remain dedicated to this principle and continue to offer pharmaceutical products with validated active components at a reasonable cost.

Liaoyuan Silver Eagle Pharmaceutical Co., Ltd., founded in 1958, formerly known as Liaoyuan tire factory, changed its name to Liaoyuan No. 3 chemical plant in 1978 and entered the chemical field. In 1989, it joined Jilin Chemical Industry Corporation and changed its name to Jihua Liaoyuan pharmaceutical No. 4 factory to manufacture pharmaceutical raw materials. In 1999, it was renamed Liaoyuan Silver Eagle Pharmaceutical Co., Ltd. through joint-stock restructuring. Since its inception, Liaoyuan Silver Eagle pharmaceutical has been adhering to the concept of quality first pharmaceutical API, so that downstream preparation manufacturers can rest assured and consumers can rest assured. Established for more than 20 years, it has been continuously recognized by customers and officials at domestic and oversea. At present, since the promulgation of China's GMP system, Liaoyuan Silver Eagle has always met the GMP management requirements. At the same time, it has obtained domestic and foreign system certifications such as FDA certification, EU CEP certification, WHO: World Health Organization certification and Japanese manufacturer qualification certificate.

Established in 1997, Vaikunth Chemicals Pvt. Ltd. is proud to introduce itself as a leading producer, supplier, and exporter of a broad array of bulk drugs and drug intermediates. With over ten years of experience, we are dedicated to delivering inventive drug solutions to our esteemed global clients. Our chemical products are manufactured using safe and hygienic methods, ensuring exceptional quality and effectiveness in every aspect. Our state-of-the-art multipurpose facility on our premises meets all GMP and international quality standards, reflecting our commitment to excellence.